Literature DB >> 28882731

Danggui Buxue decoction promotes angiogenesis by up-regulation of VEGFR1/2 expressions and down-regulation of sVEGFR1/2 expression in myocardial infarction rat.

Guanying Hu1, Peng Yang2, Yu Zeng3, Sanyin Zhang4, Jiage Song3.   

Abstract

BACKGROUND: The traditional herbal compound Danggui Buxue decoction (DBD), has long been used for the prevention and treatment of cardiovascular diseases, however, the underlying molecular mechanism for its effect remains still unknown. So this study would to investigate the effect of DBD on cardiac damage induced by myocardial infarction (MI) challenge.
METHODS: SD Rats with ligation of left anterior descending (LAD) coronary artery were randomly divided into MI, MI plus Betaloc Zok, MI plus DBD high dose, and MI plus DBD low dose group, together with sham-operated group. After corresponding treatment for consecutive 4 weeks, cardiac function was evaluated by hemodynamics with the method of pressure-volume conduit system. Cardiac histological morphology, microvascular density and the expressions of VEGF and VEGFR1/2 mRNA and their relative protein including VEGF, membranous VEGFR1 (VEGFR1), soluble VEGFR1 (sVEGFR1), VEGFR2, and sVEGFR2 were examined by hematoxylin & eosin staining, immunohistochemical staining and quantitative polymerase chain reaction and western blot assay, respectively.
RESULTS: It showed that a significant impaired cardiac function and a remarkably inducible increase in fibrotic scar formation, microvascular density and VEGF mRNA expressions in MI rats. While DBD treatment could markedly boost cardiac angiogenesis further, hinder fibrotic scar formation, and improve declined cardiac function. Apart from the up-regulation of VEGF mRNA and VEGF and the down-regulation of sVEGFR1/2, high dose of DBD dedicated to increasing VEGFR1 mRNA and VEGFR1 expression, while low dose to elevating VEGFR2 mRNA and VEGFR2 expression.
CONCLUSION: The present study demonstrated that DBD could accelerate cardiac angiogenesis, restrain fibrous scar formation and thus ameliorate cardiac function in post-MI, via the active regulation of VEGF/VEGFRs signaling pathway.
Copyright © 2017. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Cardiac angiogenesis; Cardiac function; Danggui buxue decoction; Myocardium infraction; VEGF; VEGFRs

Mesh:

Substances:

Year:  2017        PMID: 28882731     DOI: 10.1016/j.jcma.2017.06.015

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  10 in total

Review 1.  The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.

Authors:  Chen-Chen Ma; Yue-Hua Jiang; Yan Wang; Rui-Rong Xu
Journal:  Curr Med Sci       Date:  2022-10-17

Review 2.  Therapeutic potential of traditional Chinese medicine for vascular endothelial growth factor.

Authors:  Yijia Mao; Lingkai Meng; Huayi Liu; Yuting Lu; Kuo Yang; Guangze Ouyang; Yanran Ban; Shuang Chen
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

3.  Network Pharmacology-Based Approach to Investigate the Mechanisms of Mahai Capsules in the Treatment of Cardiovascular Diseases.

Authors:  Minjuan Shi; Bo Li; Qiuzhen Yuan; Xuefeng Gan; Xiao Ren; Shanshan Jiang; Zhuo Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-12       Impact factor: 2.629

4.  Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathway.

Authors:  Feng Min; Xian Jie Jia; Qin Gao; Fang Niu; Zhi Yuan Hu; Ya Ling Han; Hong Jie Shi; Ying Yu
Journal:  Exp Ther Med       Date:  2019-11-08       Impact factor: 2.447

5.  Danggui Buxue Decoction Ameliorates Inflammatory Bowel Disease by Improving Inflammation and Rebuilding Intestinal Mucosal Barrier.

Authors:  Chengyin Li; Fenglin Zhu; Shasha Wang; Jing Wang; Bin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-19       Impact factor: 2.629

6.  Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation.

Authors:  Shi-Han Feng; Bin Zhao; Xue Zhan; Retsepile Motanyane; Shu-Mei Wang; Ao Li
Journal:  Drug Des Devel Ther       Date:  2021-02-24       Impact factor: 4.162

7.  Ultrafiltration Extract of Radix Angelica Sinensis and Radix Hedysari Attenuates Risk of Low-Dose X-Ray Radiation-Induced Myocardial Fibrosis In Vitro.

Authors:  Juan Chang; Chengxu Ma; Huan Guo; Haiqiong Ran; Guolian Chen; Yingdong Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-28       Impact factor: 2.629

Review 8.  Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

Authors:  Anzhu Wang; Wei Zhao; Kaituo Yan; Pingping Huang; Hongwei Zhang; Zhibo Zhang; Dawu Zhang; Xiaochang Ma
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

9.  Yiqihuoxue decoction protects against post-myocardial infarction injury via activation of cardiomyocytes PGC-1α expression.

Authors:  Fanghe Li; Shuwen Guo; Chunguo Wang; Xiaolou Huang; Hui Wang; Xiaobo Tan; Qian Cai; Jiani Wu; Yuqin Zhang; Xi Chen; Wangou Lin; Binyue Zhang
Journal:  BMC Complement Altern Med       Date:  2018-09-17       Impact factor: 3.659

10.  Exploring the mechanism of Danggui Buxue Decoction in regulating atherosclerotic disease network based on integrated pharmacological methods.

Authors:  Hao Xu; Tianqing Zhang; Ling He; Mengxia Yuan; Xiao Yuan; Shanshan Wang
Journal:  Biosci Rep       Date:  2021-10-29       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.